腺苷
输送系统
医学
药理学
核苷
全身给药
化学
内科学
体内
生物
生物化学
生物技术
作者
Mehdi Kazemzadeh‐Narbat,Nasim Annabi,Ali Tamayol,Rahmi Öklü,Amyl Ghanem,Ali Khademhosseini
标识
DOI:10.3109/1061186x.2015.1058803
摘要
Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosine's extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.
科研通智能强力驱动
Strongly Powered by AbleSci AI